Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) FCF Margin (2019 - 2023)

Benitec Biopharma has reported FCF Margin over the past 5 years, most recently at 58514.29% for Q2 2023.

  • Quarterly results put FCF Margin at 58514.29% for Q2 2023, changed N/A from a year ago — trailing twelve months through Mar 2024 was 288514.29% (down 26088782.0% YoY), and the annual figure for FY2023 was 24017.33%, down 221870.0%.
  • FCF Margin reached 58514.29% in Q2 2023 per BNTC's latest filing, down from 7438.89% in the prior quarter.
  • Across five years, FCF Margin topped out at 9022.86% in Q2 2020 and bottomed at 350000.0% in Q4 2020.
  • Median FCF Margin over the past 5 years was 7438.89% (2023), compared with a mean of 71674.39%.
  • The largest annual shift saw FCF Margin tumbled -34600519bps in 2020 before it skyrocketed 33671200bps in 2021.
  • Over 5 years, FCF Margin stood at 3994.81% in 2019, then crashed by -8661bps to 350000.0% in 2020, then skyrocketed by 96bps to 13288.0% in 2021, then plummeted by -215bps to 41821.43% in 2022, then tumbled by -40bps to 58514.29% in 2023.
  • Business Quant data shows FCF Margin for BNTC at 58514.29% in Q2 2023, 7438.89% in Q1 2023, and 41821.43% in Q4 2022.